Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRPS-VITC
2024-518310-28-00Phase 3Authorised
- Sponsor
- CHU Amiens-Picardie
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) comparing Vitamin C with Placebo (2 arms). Primary endpoint: Incidence of complex regional pain syndrome at 6 months. Planned start Oct 2024; status: authorised.
02
Drugs
ascorbic acid
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2024-518310-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518310-28-00.